David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 5,700 shares at $2.41 ($14K) on 2016-01-29, disclosed to the SEC on 2016-02-02.
Scheduled purchase ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 1,200 | $3K | 21.3% |
| 2 | $2.37 | 4,500 | $11K | 78.7% |
| Total | $2.38 avg | 5,700 | $14K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |